Methotrexate Monotherapy for Unilateral Active Thyroid-Related Eye
Disease
- Ayman Elnahry
, - Joseph Talbet,
- Gehad Elnahry
Gehad Elnahry
Cairo University Kasr Alainy Faculty of Medicine
Author ProfileAbstract
A type 1 diabetic patient with unilateral active thyroid-related eye
disease was intolerant to systemic steroid therapy due to uncontrollable
blood sugar levels. She was treated with low-dose methotrexate
monotherapy which resulted in a marked improvement of her condition with
no adverse events.10 Apr 2021Submitted to Clinical Case Reports 12 Apr 2021Submission Checks Completed
12 Apr 2021Assigned to Editor
22 Apr 2021Reviewer(s) Assigned
22 May 2021Review(s) Completed, Editorial Evaluation Pending
22 May 2021Editorial Decision: Revise Minor
23 May 20211st Revision Received
28 May 2021Assigned to Editor
28 May 2021Submission Checks Completed
28 May 2021Review(s) Completed, Editorial Evaluation Pending
29 May 2021Reviewer(s) Assigned
09 Jun 2021Editorial Decision: Revise Minor
09 Jun 20212nd Revision Received
10 Jun 2021Submission Checks Completed
10 Jun 2021Assigned to Editor
10 Jun 2021Review(s) Completed, Editorial Evaluation Pending
10 Jun 2021Editorial Decision: Revise Minor
10 Jun 20213rd Revision Received
11 Jun 2021Assigned to Editor
11 Jun 2021Submission Checks Completed
11 Jun 2021Review(s) Completed, Editorial Evaluation Pending
21 Jun 2021Editorial Decision: Accept
